|
MYOV
|
Myovant Sciences Ltd.
|
US
|
NYSE
|
|
MYRX
|
Myrexis Inc
|
US
|
OTC
|
|
N1VO34
|
Novo Nordisk A/S
|
BR
|
SA
|
|
NAMSW
|
NewAmsterdam Pharma Company N.V. Warrant
|
US
|
US
|
|
NAVB
|
Navidea Biopharmaceuticals, Inc.
|
US
|
AMEX
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
US
|
NASDAQ
|
|
NC6
|
Nanollose Ltd
|
AU
|
ASX
|
|
NCNA
|
NuCana plc
|
US
|
NASDAQ
|
|
NERV
|
Minerva Neurosciences, Inc
|
US
|
NASDAQ
|
|
NGRC
|
National Graphite Corp
|
US
|
OTC
|
|
NLSPW
|
NLS Pharmaceutics AG
|
US
|
US
|
|
NLTX
|
Neoleukin Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NNBP
|
Nanobac Pharmaceuticals Incorporated
|
US
|
US
|
|
NNVC
|
NanoViricides, Inc.
|
US
|
AMEX
|
|
NOX
|
Noxopharm Ltd
|
AU
|
ASX
|
|
NPHC
|
Nutra Pharma Corp
|
US
|
OTC
|
|
NRX
|
NurExone Biologic Inc.
|
CA
|
V
|
|
NRXPW
|
NRx Pharmaceuticals Inc
|
US
|
US
|
|
NSB
|
NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
|
AU
|
ASX
|
|
NSTM
|
Novelstem International Corp.
|
US
|
OTC
|